Avalo Therapeutics, Inc. (AVTX) EV to EBIT (2017 - 2018)
Avalo Therapeutics' EV to EBIT came in at 17.95 for Q2 2018, up 63.2% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics, Inc. (AVTX) EV to EBIT (2017 - 2018) Analysis & Trends
Over the trailing twelve months to Jun 30, 2018, Avalo Therapeutics reported EV to EBIT of 14.34; for FY2017, it was 10.54.
- Business Quant data shows AVTX's EV to EBIT at 11.00 (Q1 2018), 10.54 (Q4 2017) and 1.48 (Q3 2017) in the three quarters before Q2 2018.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 17.95 |
| Mar 31, 2018 | 11.00 |
| Dec 31, 2017 | 10.54 |
| Sep 30, 2017 | 1.48 |
API Access
Avalo Therapeutics, Inc. EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();